Company

tearsolutions.com

Rocket Ship Rating

Rocket Ship Rating: 92 out of 100

NATURAL THERAPY FOR OCULAR SURFACE DISEASE

Also known as TearSolutions, TearSolutions, Inc.

Biotech & therapeutics

Status: Operatingas of 2026-09-20
Business model: B2B
Headquarters: Charlottesville, Virginia, United States
Founded: 2013
Legal name: TearSolutions, Inc.

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

Developing Potentially Disruptive Therapies for the Treatment of Ocular Surface Related Diseases

Funding snapshot

Total raised: $39.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Series A, $3M

Funding rounds

Round, 2025: $517K2025-10-29, SEC form D sold, 12 investors
Round, 2024: $12.7M2024-09-25, SEC form D sold, 80 investors
Round, 2023: $390K2023-09-08, SEC form D sold, 10 investors
Round, 2021: $5.6M2021-07-16, SEC form D sold, 44 investors
Round, 2020: $1.5M2020-02-12, SEC form D sold, 36 investors
Round, 2019: $1.3M2019-03-04, SEC form D sold, 16 investors
Round, 2019: $5.1M2019-03-04, SEC form D sold, 22 investors
Round, 2017: $8.1M2017-12-04, SEC form D sold, 24 investors
Round, 2017: $3.4M2017-01-18, SEC form D sold, 22 investors
Round, 2014: $500K2014-10-30, SEC form D sold, 1 investor
Round, 2014: $390K2014-05-06, SEC form D sold, 5 investors
Series B: $8.5MCompany stated
Series B: $3MCompany stated

Products

Other: Lacripep